Clinical Trials at Montefiore Nyack Hospital

Clinical trials are medical research studies that look for new ways to prevent, detect or treat disease. There are many kinds of clinical trials. Some test new drugs, while others look at new surgical procedures or devices, or new ways to use current treatments.

People who participate in a clinical trial can contribute to finding new treatments and cures for diseases. If you participate, you will be helping others in the future, but you might receive a novel treatment, and you will have extra care and attention from the medical research staff.

At Montefiore Nyack Hospital, patients who choose to participate in a cancer clinical trial receive comprehensive, advanced care, sometimes well before it is available anywhere else.

For frequently asked questions, click here >

A Randomize Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 negative Breast Cancer.
(Alliance)

Jun 25, 2019 - A Phase III Double-blind Randomised Study Assessing the Efficacy and Safety of Capivasertib + Paclitaxel Versus Placebo +...

MammaPrint, BluePrint and Full –Genome Data Linked with Clinical Data to Evaluate New Gene Expression Profiles. An Adaptable Registry.

Prospective Evaluation of Carvediol in Prevention of Cardiac Toxicity in Patients with Metastatic HER 2+ Breast Cancer.
(SWOG)

A multi-center, double-blind, placebo-controlled, randomized phase II trial to compare efficacy of xentuzumab in combination with everolimus and...

This is a prospective survivorship cohort study of adult patients with CSCC who receives treatment with commercially available cemiplimab.

A Phase II Open-Label Prospective, Single-Arm study to assess ability of Eltrombopag to induce Sustained remission in subjects with ITP who are...

A multicenter, Double-Blind, Randomized, Controlled study of M7824 with Concurrent Chemoradiation followed by M7824 vs Concurrent Chemoradiation...

A Phase III, Randomized, Double- Blind, Placebo-Controlled, Multicenter study to evaluate the Efficacy and Safety of Anamorelin HCL for the...

Phase III, Randomized, Double-blind, controlled, Multicenter study of IV PI3K inhibitor copanlisb in combination with standard immunochemotherapy...

Pages